Detalles de la búsqueda
1.
Ratiometric activatable cell-penetrating peptides label pancreatic cancer, enabling fluorescence-guided surgery, which reduces metastases and recurrence in orthotopic mouse models.
Ann Surg Oncol
; 22(6): 2082-7, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25319581
2.
Fluorescence-guided surgery with a fluorophore-conjugated antibody to carcinoembryonic antigen (CEA), that highlights the tumor, improves surgical resection and increases survival in orthotopic mouse models of human pancreatic cancer.
Ann Surg Oncol
; 21(4): 1405-11, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24499827
3.
Fluorescently labeled chimeric anti-CEA antibody improves detection and resection of human colon cancer in a patient-derived orthotopic xenograft (PDOX) nude mouse model.
J Surg Oncol
; 109(5): 451-8, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24249594
4.
In vivo fluorescence imaging of gastrointestinal stromal tumors using fluorophore-conjugated anti-KIT antibody.
Ann Surg Oncol
; 20 Suppl 3: S693-700, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23943029
5.
In vivo serial selection of human pancreatic cancer cells in orthotopic mouse models produces high metastatic variants irrespective of Kras status.
J Surg Res
; 184(1): 290-8, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23590868
6.
Fluorescence-guided surgery of human colon cancer increases complete resection resulting in cures in an orthotopic nude mouse model.
J Surg Res
; 179(1): 87-93, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23079571
7.
Tumor-specific fluorescence antibody imaging enables accurate staging laparoscopy in an orthotopic model of pancreatic cancer.
Hepatogastroenterology
; 59(118): 1994-9, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22369743
8.
Advantages of fluorescence-guided laparoscopic surgery of pancreatic cancer labeled with fluorescent anti-carcinoembryonic antigen antibodies in an orthotopic mouse model.
J Am Coll Surg
; 219(1): 132-41, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24768506
9.
A hypusine-eIF5A-PEAK1 switch regulates the pathogenesis of pancreatic cancer.
Cancer Res
; 74(22): 6671-81, 2014 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25261239
10.
Successful fluorescence-guided surgery on human colon cancer patient-derived orthotopic xenograft mouse models using a fluorophore-conjugated anti-CEA antibody and a portable imaging system.
J Laparoendosc Adv Surg Tech A
; 24(4): 241-7, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24494971
11.
Fluorescence-guided surgery and fluorescence laparoscopy for gastrointestinal cancers in clinically-relevant mouse models.
Gastroenterol Res Pract
; 2013: 290634, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23533387
12.
Incidence and survival patterns of rare anal canal neoplasms using the surveillance epidemiology and end results registry.
Am Surg
; 79(10): 1068-74, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24160801
13.
Fluorescence-guided surgery allows for more complete resection of pancreatic cancer, resulting in longer disease-free survival compared with standard surgery in orthotopic mouse models.
J Am Coll Surg
; 215(1): 126-35; discussion 135-6, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22632917
14.
An LED light source and novel fluorophore combinations improve fluorescence laparoscopic detection of metastatic pancreatic cancer in orthotopic mouse models.
J Am Coll Surg
; 214(6): 997-1007.e2, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22542065
15.
KRas induces a Src/PEAK1/ErbB2 kinase amplification loop that drives metastatic growth and therapy resistance in pancreatic cancer.
Cancer Res
; 72(10): 2554-64, 2012 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22589274
16.
Submillimeter-resolution fluorescence laparoscopy of pancreatic cancer in a carcinomatosis mouse model visualizes metastases not seen with standard laparoscopy.
J Laparoendosc Adv Surg Tech A
; 21(6): 485-9, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21699431
Resultados
1 -
16
de 16
1
Próxima >
>>